| Evaluation of the prognostic value of LMR, PLR, NLR, and dNLR in urothelial bladder cancer patients treated with radical cystectomy. P Rajwa, M Życzkowski, A Paradysz, K Bujak, P Bryniarski European Review for Medical & Pharmacological Sciences 22 (10), 2018 | 74 | 2018 |
| Reliability of serial prostate magnetic resonance imaging to detect prostate cancer progression during active surveillance: a systematic review and meta-analysis P Rajwa, B Pradere, F Quhal, K Mori, E Laukhtina, NA Huebner, ... European urology 80 (5), 549-563, 2021 | 73 | 2021 |
| Androgen receptor signaling inhibitors in addition to docetaxel with androgen deprivation therapy for metastatic hormone-sensitive prostate cancer: a systematic review and meta … T Yanagisawa, P Rajwa, C Thibault, G Gandaglia, K Mori, T Kawada, ... European urology 82 (6), 584-598, 2022 | 58 | 2022 |
| Online crowdfunding response to coronavirus disease 2019 P Rajwa, P Hopen, L Mu, A Paradysz, J Wojnarowicz, CP Gross, ... Journal of general internal medicine 35, 2482-2484, 2020 | 50 | 2020 |
| Diagnostic accuracy of novel urinary biomarker tests in non–muscle-invasive bladder cancer: a systematic review and network meta-analysis E Laukhtina, SR Shim, K Mori, DA David, F Soria, P Rajwa, H Mostafaei, ... European urology oncology 4 (6), 927-942, 2021 | 49 | 2021 |
| Diagnostic performance of prostate-specific membrane antigen positron emission tomography–targeted biopsy for detection of clinically significant prostate cancer: a systematic … T Kawada, T Yanagisawa, P Rajwa, RS Motlagh, H Mostafaei, F Quhal, ... European urology oncology 5 (4), 390-400, 2022 | 38 | 2022 |
| En Bloc Resection for Bladder Tumors: An Updated Systematic Review and Meta-Analysis of Its Differential Effect on Safety, Recurrence and Histopathology T Yanagisawa, K Mori, RS Motlagh, T Kawada, H Mostafaei, F Quhal, ... The Journal of Urology 207 (4), 754-768, 2022 | 38 | 2022 |
| Active surveillance for intermediate-risk prostate cancer: a systematic review, meta-analysis, and metaregression M Baboudjian, A Breda, P Rajwa, A Gallioli, B Gondran-Tellier, ... European Urology Oncology 5 (6), 617-627, 2022 | 32 | 2022 |
| The comparison of laparoscopic and microsurgical varicocoelectomy in infertile men with varicocoele on paternity rate 12 months after surgery: a prospective randomized … P Bryniarski, P Taborowski, P Rajwa, Z Kaletka, M Życzkowski, ... Andrology 5 (3), 445-450, 2017 | 31 | 2017 |
| Association between SARS-CoV-2 infection and disease severity among prostate cancer patients on androgen deprivation therapy: a systematic review and meta-analysis R Sari Motlagh, M Abufaraj, PI Karakiewicz, P Rajwa, K Mori, DH Mun, ... World Journal of Urology, 1-8, 2022 | 30 | 2022 |
| Discordance between clinical and pathological staging and grading in upper tract urothelial carcinoma K Mori, S Katayama, E Laukhtina, VM Schuettfort, B Pradere, F Quhal, ... Clinical Genitourinary Cancer 20 (1), 95. e1-95. e6, 2022 | 30 | 2022 |
| The prognostic association of prostate MRI PI-RADS™ v2 assessment category and risk of biochemical recurrence after definitive local therapy for prostate cancer: a systematic … P Rajwa, K Mori, NA Huebner, DT Martin, PC Sprenkle, JC Weinreb, ... Journal of Urology 206 (3), 507-516, 2021 | 29 | 2021 |
| The relationship between red cell distribution width and cancer-specific survival in patients with renal cell carcinoma treated with partial and radical nephrectomy M Życzkowski, P Rajwa, E Gabrys, K Jakubowska, E Jantos, A Paradysz Clinical genitourinary cancer 16 (3), e677-e683, 2018 | 29 | 2018 |
| Pretreatment clinical and hematologic prognostic factors of metastatic urothelial carcinoma treated with pembrolizumab: a systematic review and meta-analysis T Yanagisawa, K Mori, S Katayama, H Mostafaei, F Quhal, E Laukhtina, ... International Journal of Clinical Oncology, 1-13, 2022 | 25 | 2022 |
| Novel hematological biomarkers predict survival in renal cell carcinoma patients treated with nephrectomy P Rajwa, M Życzkowski, A Paradysz, M Slabon-Turska, K Suliga, K Bujak, ... Archives of Medical Science 13 (1), 2020 | 25 | 2020 |
| Differential efficacy of ablation therapy versus partial nephrectomy between clinical T1a and T1b renal tumors: a systematic review and meta-analysis T Yanagisawa, K Mori, T Kawada, RS Motlagh, H Mostafaei, F Quhal, ... Urologic Oncology: Seminars and Original Investigations 40 (7), 315-330, 2022 | 24 | 2022 |
| Prognostic value of the systemic immune-inflammation index in non-muscle invasive bladder cancer S Katayama, K Mori, B Pradere, E Laukhtina, VM Schuettfort, F Quhal, ... World Journal of Urology 39 (12), 4355-4361, 2021 | 22 | 2021 |
| Adjuvant therapy with tyrosine kinase inhibitors for localized and locally advanced renal cell carcinoma: an updated systematic review and meta-analysis E Laukhtina, F Quhal, K Mori, RS Motlagh, B Pradere, VM Schuettfort, ... Urologic Oncology: Seminars and Original Investigations 39 (11), 764-773, 2021 | 21 | 2021 |
| Accuracy of frozen section analysis of urethral and ureteral margins during radical cystectomy for bladder cancer: a systematic review and diagnostic meta-analysis E Laukhtina, P Rajwa, K Mori, M Moschini, D D’Andrea, M Abufaraj, ... European Urology Focus 8 (3), 752-760, 2022 | 20 | 2022 |
| Impact of systemic Immune–inflammation Index on oncologic outcomes in patients treated with radical prostatectomy for clinically nonmetastatic prostate cancer P Rajwa, VM Schuettfort, D D'Andrea, F Quhal, K Mori, S Katayama, ... Urologic Oncology: Seminars and Original Investigations 39 (11), 785. e19 …, 2021 | 20 | 2021 |
Ekaterina LaukhtinaMedical University of ViennaVerified email at meduniwien.ac.at
